In vitro evaluation of voriconazole against some clinically important fungi.
AUTOR(ES)
McGinnis, M R
RESUMO
Voriconazole was compared to amphotericin B, fluconazole, and itraconazole by using an in vitro macrobroth dilution test based upon current National Committee for Clinical Laboratory Standards tentative standards against the dimorphic fungi and several opportunistic molds and yeasts. In all instances, the voriconazole MICs were lower than those of fluconazole. In most instances, the MICs were lower than the recorded MICs of amphotericin B and itraconazole.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=164017Documentos Relacionados
- Compounds active against cell walls of medically important fungi.
- In Vitro Antifungal Activities of the New Triazole UR-9825 against Clinically Important Filamentous Fungi
- Evaluation of proteolytic activity to differentiate some dematiaceous fungi.
- In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi
- Virulence factors of medically important fungi.
